ENT Devices

ENT Devices Market Revenue Will Grow 1.8x From 2022 To 2032

Healthcare

ENT Devices Market Outlook

Global sales of ENT Devices market in 2021 was held at US$ 21.9 Bn. With 6.1%, the projected market growth during 2022 – 2032 is expected to be significantly higher than the historical growth. The absolute dollar opportunity for ENT Devices market will be witnessing US$ 18.5 Bn absolute $ opportunity.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7199

Market Segments Covered in ENT Devices Industry Analysis

  • By Product Type :

    • Diagnostic ENT Devices
      • Rigid Endoscopes
      • Flexible Endoscopes
      • Robot Assisted Endoscope
      • Hearing Screening Device
    • Surgical ENT Devices
      • Radiofrequency Handpieces
      • Otological Drill Burrs
      • ENT Hand Instruments
      • Sinus Dilation Devices
      • Nasal Packing Devices
    • Hearing Aids
    • Hearing Implants
    • Nasal Splints
  • By Region :

    • North America
    • Latin America
    • Europe
    • APAC
    • MEA

Competitive Analysis

The ENT devices market is significantly competitive where a handful of players dominate the market. The key market players of the studied market comprise Medtronic, Acclarent, Demant A/S, Sonova, Ambu A/S., Pentax Medical, Karl Storz, Olympus Corporation, Richard Wolf Gmbh, Widex, Cochlear Ltd., Sivantos, Inc., Starkey Hearing Technologies, Gn Resound A/S, Rion Co., Ltd., Welch Allyn, Atos Medical AB, and Zsquare.

The recent development in ent devices markets are:

  • In March 2022Zsquare, a developer of high-performance, single-use endoscopes, has received US$ 15 Mn worth of equity financing from a joint venture investment group as the part of its soft-launch of its disruptor next-generation ENT endoscope. The soft-launch will take place following federal FDA approval anticipated in the third quarter of 2022.
  • In Feb 2022Medtronic plc announced the introduction of NuVentTM balloon, which the FDA approved for lasting treatment of chronic, obstructive Eustachian Tube Dysfunction. The NuVent balloon allows for speedy outpatient or in-office treatment.
  • In September 2021Acclarent announced the launch of its ENT technology, which uses AI to simplify surgical planning provide real-time feedback during ENT navigation procedures. Initially the system will be limited to the U.S. The new software package contains TruSeg and TruPath for use with the TruDi Navigation System and leverages a machine learning algorithm to provide reliable and efficient image guided preoperative planning and navigation for ENT procedures, such as endoscopic sinus surgery.
  • In August 2021Medtronic announced that it has reached an agreement to acquire Covidien’s ENT devices business for $1.1 B in cash. The move is expected to help Medtronic expand its presence in the growing global market for ENT devices. The acquisition is also expected to provide Medtronic with a stronger product portfolio and increase its market share in key geographies.

Leave a Reply

Related Posts